Westlake Chemical Partners LP (WLKP) Cash Flow Statement
Where WLKP’s cash came from and went, 2025
December 31, 2025 · U.S. dollars- Cash from operations
- $280.5M −42.2% vs 2024
- Capital expenditures
- $78.8M 6.8% of revenue
- Free cash flow
- $201.7M 17.3% margin
- Returned to shareholders
- $66.5M 33% of free cash flow
- Change in cash
- −$14.0M cash at year-end $44.3M
Drawn to scale: where the cash came from and how it was used. Hover for values.
WLKP operating cash flow, capex and free cash flow
WLKP cash flow trends, 2016–2025
| Metric | Trend | Then | Latest | Change |
|---|---|---|---|---|
| Operating cash flow | $287.7M2016 | $280.5M2025 | −0.3%/yr | |
| Capital expenditures | $299.6M2016 | $78.8M2025 | −13.8%/yr | |
| Free cash flow | −$11.9M2016 | $201.7M2025 | — | |
| Free cash flow margin | −1.2%2016 | 17.3%2025 | +18.5 pts | |
| Operating cash flow / net income | 0.812016 | 0.942025 | +0.13 | |
| Stock-based compensation | $194,0002016 | $349,0002023 | +8.8%/yr | |
| Dividends paid | $34.9M2016 | $66.5M2025 | +7.4%/yr | |
| Share buybacks (net) | $244.6M2016 | $337.6M2022 | +5.5%/yr | |
| Capex / revenue | 30.4%2016 | 6.8%2025 | −23.6 pts |
Change is the average annual growth (CAGR) or the difference between the first and latest year.
WLKP cash flow by activity
WLKP net income vs operating cash flow
Operating cash flow above net income usually means earnings are backed by cash (depreciation and stock-based pay are non-cash expenses).
WLKP cash flow statement
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating activities | ||||||||||
| Net income | $298.6M | $369.2M | $54.3M | $334.8M | $401.4M | $341.1M | $332.9M | $330.6M | $353.1M | $353.4M |
| Depreciation & amortization | $128.0M | $111.9M | $110.2M | $121.1M | $108.8M | $103.2M | $107.3M | $108.8M | $114.0M | $98.2M |
| Stock-based compensation | — | — | $349,000 | $282,000 | $436,000 | $375,000 | $387,000 | $363,000 | $289,000 | $194,000 |
| Change in working capital | −$148.8M | $1.8M | $2.3M | $7.8M | −$105.7M | −$71.6M | $10.5M | −$3.3M | $70.3M | −$163.9M |
| Other non-cash items | $2.7M | $2.2M | $284.9M | −$282,000 | $3.5M | $356,000 | −$331,000 | −$363,000 | −$289,000 | −$194,000 |
| Cash from operating activities | $280.5M | $485.0M | $452.0M | $463.7M | $408.4M | $373.4M | $450.8M | $436.2M | $537.4M | $287.7M |
| Investing activities | ||||||||||
| Capital expenditures | −$78.8M | −$49.0M | −$46.8M | −$54.1M | −$81.2M | −$37.0M | −$43.7M | −$39.9M | −$68.9M | −$299.6M |
| Investments (net) | $110.0M | −$89.0M | $9.4M | −$12.0M | −$64.3M | $2.0M | −$57.7M | −$51.8M | −$203.2M | −$299.5M |
| Acquisitions & other investing | $0 | $49.0M | −$38.5M | $54.1M | $81.2M | $37.0M | $43.7M | $39.9M | $68.9M | $299.6M |
| Cash from investing activities | $31.2M | −$89.0M | −$75.9M | −$12.0M | −$64.3M | $2.0M | −$57.7M | −$51.8M | −$203.2M | −$299.5M |
| Financing activities | ||||||||||
| Dividends paid | −$66.5M | −$66.4M | −$66.4M | −$66.4M | −$66.4M | −$66.4M | −$62.1M | −$53.4M | −$42.1M | −$34.9M |
| Share repurchases & issuance (net) | — | — | — | −$337.6M | −$277.9M | −$311.8M | $123.5M | −$341.9M | $165.3M | −$244.6M |
| Net borrowing (repayment) | $0 | $0 | $0 | $0 | $0 | — | −$77.9M | $3.6M | −$120.7M | $210.6M |
| Shares issued | $0 | $0 | $0 | $0 | $0 | $0 | $62.7M | $0 | $0 | $0 |
| Other financing | −$259.2M | −$329.9M | −$315.8M | $0 | $0 | $0 | −$439.1M | $0 | −$398.5M | $0 |
| Cash from financing activities | −$325.7M | −$396.3M | −$382.2M | −$404.0M | −$344.2M | −$378.2M | −$392.9M | −$391.6M | −$396.0M | −$68.9M |
| Summary | ||||||||||
| Net change in cash | −$14.0M | −$303,000 | −$6.2M | $47.7M | −$97,000 | −$2.8M | $179,000 | −$7.3M | −$61.9M | −$80.7M |
| Cash at end of period | $44.3M | $58.3M | $58.6M | $64.8M | $17.1M | $17.2M | $19.9M | $19.7M | $27.0M | $88.9M |
| Free cash flow | $201.7M | $436.0M | $405.2M | $409.6M | $327.3M | $336.4M | $407.1M | $396.3M | $468.5M | −$11.9M |
| Free cash flow margin | 17.3% | 38.4% | 34.0% | 25.7% | 26.9% | 34.8% | 37.3% | 30.8% | 39.9% | −1.2% |
| Capex / revenue | 6.8% | 4.3% | 3.9% | 3.4% | 6.7% | 3.8% | 4.0% | 3.1% | 5.9% | 30.4% |
| Operating cash flow / net income | 0.94 | 1.31 | 8.33 | 1.38 | 1.02 | 1.09 | 1.35 | 1.32 | 1.52 | 0.81 |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating activities | ||||||||||||
| Net income | $82.4M | $81.7M | $84.3M | $86.2M | $85.8M | $42.3M | $87.4M | $18.1M | $14.4M | $14.8M | $14.3M | $80.9M |
| Depreciation & amortization | $35.0M | $34.3M | $34.6M | $33.9M | $32.5M | $27.1M | $27.5M | $28.1M | $28.3M | $28.0M | $28.3M | $28.2M |
| Stock-based compensation | — | — | — | — | — | — | — | — | — | — | $349,000 | — |
| Change in working capital | $10.2M | −$5.9M | $1.2M | −$16.7M | −$109.5M | −$23.8M | $17.7M | −$6.5M | $4.2M | −$13.6M | −$8.2M | −$11.8M |
| Other non-cash items | $2.2M | $131,000 | $372,000 | $1.8M | $284,000 | $240,000 | −$64,000 | $86.3M | $74.9M | $75.3M | $73.0M | $3.6M |
| Cash from operating activities | $129.8M | $110.2M | $120.4M | $105.2M | $9.1M | $45.8M | $132.5M | $126.1M | $121.9M | $104.6M | $107.7M | $100.9M |
| Investing activities | ||||||||||||
| Capital expenditures | −$12.5M | −$5.6M | −$8.8M | −$29.7M | −$24.4M | −$16.0M | −$13.5M | −$15.5M | −$10.2M | −$9.8M | −$12.8M | −$16.8M |
| Investments (net) | −$7.0M | −$13.0M | −$10.0M | $348,000 | $35.6M | $14.0M | −$38.5M | −$30.5M | −$10.2M | −$9.8M | −$22.8M | −$6.8M |
| Acquisitions & other investing | $0 | $0 | $0 | $29.7M | $24.4M | $16.0M | $13.5M | $15.5M | $10.2M | $9.8M | $12.8M | $16.8M |
| Cash from investing activities | −$19.5M | −$18.6M | −$18.8M | $348,000 | $35.6M | $14.0M | −$38.5M | −$30.5M | −$10.2M | −$9.8M | −$22.8M | −$6.8M |
| Financing activities | ||||||||||||
| Dividends paid | −$16.6M | −$16.6M | −$16.6M | −$16.6M | −$16.6M | −$16.6M | −$16.6M | −$16.6M | −$16.6M | −$16.6M | −$16.6M | −$16.6M |
| Net borrowing (repayment) | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | — | — | — | — |
| Shares issued | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other financing | −$88.7M | −$75.0M | −$78.6M | −$87.6M | −$41.1M | −$51.9M | −$79.3M | −$84.7M | −$84.9M | −$81.0M | −$75.5M | −$71.1M |
| Cash from financing activities | −$105.3M | −$91.6M | −$95.2M | −$104.2M | −$57.7M | −$68.5M | −$95.9M | −$101.3M | −$101.5M | −$97.7M | −$92.1M | −$87.7M |
| Summary | ||||||||||||
| Net change in cash | $5.0M | $21,000 | $6.3M | $1.4M | −$13.0M | −$8.7M | −$1.9M | −$5.8M | $10.2M | −$2.9M | −$7.2M | $6.4M |
| Cash at end of period | $49.3M | $44.3M | $44.3M | $37.9M | $36.6M | $49.6M | $58.3M | $60.2M | $66.0M | $55.8M | $58.6M | $65.9M |
| Free cash flow | $117.4M | $104.6M | $111.5M | $75.6M | −$15.3M | $29.8M | $119.0M | $110.5M | $111.7M | $94.8M | $94.8M | $84.1M |
| Free cash flow margin | 39.5% | 34.2% | 34.5% | 24.5% | −5.2% | 12.6% | 41.0% | 39.9% | 39.3% | 33.3% | 31.9% | 26.1% |
| Capex / revenue | 4.2% | 1.8% | 2.7% | 9.6% | 8.2% | 6.7% | 4.6% | 5.6% | 3.6% | 3.4% | 4.3% | 5.2% |
| Operating cash flow / net income | 1.58 | 1.35 | 1.43 | 1.22 | 0.11 | 1.08 | 1.52 | 6.95 | 8.45 | 7.05 | 7.53 | 1.25 |
Negative numbers are cash paid out. Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported; data from EODHD.
WLKP cash generation
In fiscal 2025 (ended December 31, 2025), Westlake Chemical Partners generated $280.5 million of cash from operations (down 42.2%) and spent $78.8 million on capital expenditures, leaving free cash flow of $201.7 million, 17.3% of revenue. It returned $66.5 million to shareholders through dividends ($66.5 million) and net share buybacks ($0). Cash and equivalents fell by $14.0 million over the year.
Related: WLKP income statement, WLKP balance sheet, WLKP dividend history. See the WLKP stock overview for the latest quote and news.
WLKP cash flow FAQ
What is Westlake Chemical Partners's free cash flow?
Westlake Chemical Partners's free cash flow was $201.7 million in fiscal 2025: $280.5 million of operating cash flow minus $78.8 million of capital expenditures It was $436.0 million a year earlier..
How much cash does Westlake Chemical Partners generate from operations?
Westlake Chemical Partners generated $280.5 million of cash from operating activities in fiscal 2025, 0.94 times its net income of $298.6 million.
How much does Westlake Chemical Partners spend on capital expenditures?
Westlake Chemical Partners spent $78.8 million on capital expenditures in fiscal 2025, 6.8% of revenue, compared with $49.0 million the year before.
How much does Westlake Chemical Partners pay in dividends?
Westlake Chemical Partners paid $66.5 million in dividends in fiscal 2025, 33.0% of free cash flow.